Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 260 | 518 | 2,138 | 1,486 | 115 |
| Cost of Goods | 121 | 168 | 813 | 891 | 65 |
| Gross Profit | 139 | 350 | 1,325 | 595 | 50 |
| Operating Expenses | 11,308 | 10,360 | 8,937 | 35,113 | 13,630 |
| Operating Income | -11,048 | -9,842 | -6,799 | -33,627 | -13,515 |
| Interest Expense | 29 | 25 | 29 | 30 | 31 |
| Other Income | 223 | 125 | 157 | 146 | 53 |
| Pre-tax Income | -10,854 | -9,742 | -6,671 | -33,511 | -13,493 |
| Net Income Continuous | -10,854 | -9,742 | -6,671 | -33,511 | -13,493 |
| Net Income | $-10,854 | $-9,742 | $-6,671 | $-33,511 | $-13,493 |
| EPS Basic Total Ops | -0.34 | -0.30 | -0.26 | -2.19 | -0.98 |
| EPS Basic Continuous Ops | -0.34 | -0.30 | -0.26 | -2.22 | -0.98 |
| EPS Diluted Total Ops | -0.34 | -0.30 | -0.26 | -2.19 | -0.98 |
| EPS Diluted Continuous Ops | -0.34 | -0.30 | -0.26 | -2.22 | -0.98 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.30 | -0.26 | 0.48 | -0.98 |
| EBITDA(a) | $-10,464 | $-9,283 | $-6,308 | $-33,064 | $-13,175 |